BioCentury
ARTICLE | Company News

RXi Pharmaceuticals, UMMS deal

January 25, 2010 8:00 AM UTC

RXi and the university will explore the application of RXi's sd-rxRNA compounds for ocular diseases such as age-related macular degeneration (AMD). The parties will use preclinical models of ocular di...